Company Filing History:
Years Active: 2014
Title: Michael P. Zimber: Innovator in CNS Treatment
Introduction
Michael P. Zimber is a notable inventor based in Mamroneck, NY (US). He has made significant contributions to the field of medical science, particularly in the treatment of central nervous system (CNS) disorders. His innovative work focuses on developing solutions for spinal cord injuries and related conditions.
Latest Patents
Michael P. Zimber holds a patent for "Fusion proteins for the treatment of CNS." This patent discloses compositions that are capable of treating spinal cord injuries and related CNS disorders. The compositions include proteoglycan degrading molecules and are designed to block or overcome the activity of neuronal growth inhibitory molecules. Additionally, the patent features fusion proteins that incorporate a proteoglycan degrading domain along with a domain that can inhibit neuronal growth inhibitors.
Career Highlights
Zimber is associated with Acorda Therapeutics, Inc., a company dedicated to developing therapies for neurological disorders. His work at Acorda Therapeutics has been instrumental in advancing treatments that improve the quality of life for individuals suffering from CNS-related issues.
Collaborations
Some of his notable coworkers include Elliott A. Gruskin and Anthony O. Caggiano. Their collaborative efforts contribute to the innovative research and development at Acorda Therapeutics.
Conclusion
Michael P. Zimber's contributions to the field of CNS treatment through his patented innovations highlight his role as a key inventor in medical science. His work continues to pave the way for advancements in therapies for spinal cord injuries and related disorders.